MET and breast carcinoma: Overexpression of miR-335 has been shown to suppress HGF-induced phosphorylation of c-Met, which could subsequently inhibit the HGF role of prompting breast cancer cell migration in a c-Met-dependent manner by targeting c-Met (Gao et al., 2015).